Special Issue "COVID-19 Vaccine Acceptance and Uptake: Insights from Behavioural and Social Sciences"
Deadline for manuscript submissions: 31 May 2024 | Viewed by 184429
Interests: COVID-19 vaccination acceptance; COVID-19 vaccination hesitancy; lockdown; knowledges; behaviours; COVID-19; legionella; legionellosis; migrants; migrant's health; legionnaires' disease; chikungunya; dengue
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Environmental Research and Public Health: Second Edition of the COVID-19 Pandemic in Europe: Response to Challenges
Special Issue in Vaccines: Vaccine and Vaccination: On Field Research
It is well known that it is not enough to simply have safe and effective vaccines in order to achieve high vaccination coverage. Indeed, vaccine hesitancy is a global problem, and behavioural sciences are key to understanding, informing, and guiding research on the acceptance and uptake of COVID-19 vaccines.
This Special Issue will gather research focusing on insights from behavioural and social sciences applied to the context of COVID-19 vaccines. Theoretical contributions, reviews and meta-analyses, and original reports are all welcomed.
Example of issues of interest include (but are not limited to): interventions to promote vaccines (e.g., nudges, inoculation or pre-bunking, presumptive communication, prosocial appeals, motivational interviewing); risk perception, confidence and trust in relation to vaccine safety, vaccine acceptance and vaccine uptake; restoring confidence after vaccine pause; decision-making processing; gaps between intentions and actual behaviours; decision making in specific contexts where evidence is lacking (e.g., pregnant women); factors involved in the decision to participate in vaccine clinical trials.
Prof. Dr. Christian Napoli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- COVID-19 vaccine hesitancy
- COVID-19 vaccine acceptance
- behavioural sciences
- social sciences
- decision making
- vaccine confidence
- risk perception
- risk communication
- public health